See what the world's top investors are buying and saying

This Week's Picks2026-07-27
This week's pulseInstitutions this week were united in scrutinizing AI concentration: Baillie Gifford noted that index trackers are overly concentrated in AI capital spending, with its SAINTS portfolio holding only about 14% exposure to AI infrastructure, and argued that adoption may be slower than expected. Hosking Partners also said AI beneficiaries contributed 85% of this year's returns, yet it remains underweight IT and profits from memory semiconductors. Harris|Oakmark, meanwhile, contended that mean reversion is still reliable, and that the MAG 7's earnings beats are anomalies that cannot be extrapolated. Cash management at gold miners is now diverging: Rick Rule criticized miners for holding dollars, which lose 7% in purchasing power annually, and advocated retaining gold instead. Elemental Royalty has already allowed shareholders to receive dividends in Tether Gold tokens.
1127 items
Jul 2026
27 Jul 2026Scottish Mortgage (Baillie Gifford)Podcast~11 min
ASML: The Printing Press of the AI Age
This article focuses on ASML's central role in AI chip manufacturing. CEO Christophe Fouquet noted that without EUV (extreme ultraviolet lithography), there would be no 3nm or 2nm nodes, and therefore no AI. ASML's EUV machines contain more than 700,000 components, making them the most complex equip
Source: Podcast transcript
24 Jul 2026Baillie GiffordDeep research~6 min
SAINTS spotlight: testing the case for resilient growth
This report from Baillie Gifford is about why they think passive index funds (like ETFs that track the market) are not neutral—they've become too concentrated in AI stocks, ignoring other growth areas…
Source: Fund website
23 Jul 2026Oakmark FundsDeep research~5 min
Why the case for value investing remains strong
This article argues value investing is still strong. Over the past decade, value strategies returned 10-11% annually, but tech stocks stole the spotlight. The S&P 500 has become a concentrated tech fu…
Source: Fund website
22 Jul 2026Scottish Mortgage (Baillie Gifford)Podcast
Portfolio Update Q2 2026
Source: Podcast transcript
21 Jul 2026Rick Rule (Rule Investment Media)Article~12 min
Paul's Notes #10 — The Poison or the Remedy?
Gold miners dig up gold—the antidote to inflation—but then sell it for cash, which loses value every year. Rick Rule argues they should hold gold instead. He shows that if Barrick Gold had kept its ca…
Source: Fund website
20 Jul 2026Hosking PartnersReport~6 min
Q2 2026 - Quarterly Report Commentary
The market is experiencing one of the biggest momentum rallies in history, with 85% of gains coming from AI-related stocks. Four stocks alone (Nvidia, Micron, Broadcom, Sandisk) are expected to contri…
Author · Omar MalikSource: Fund website
17 Jul 2026Baillie GiffordDeep research~5 min
SpaceX: why US Growth invested at the IPO
SpaceX went public at an eye-popping $1.7 trillion valuation. But Baillie Gifford, a long-time private investor, still bought in. Why? They see real substance: SpaceX launches over 80% of global paylo…
Source: Fund website
16 Jul 2026Hosking PartnersReport~11 min
Fit for Purpose
When choosing a fund, don't just look at the star manager. Research shows that a fund's internal structure—like whether decisions are made by a team of independent managers or a single person—explains…
Author · Luke BridgemanSource: Fund website
16 Jul 2026Baillie GiffordDeep research~5 min
Edinburgh Worldwide enlightenment: targeting cancer’s greasy ball
This article is about Revolution Medicines, a biotech firm targeting a protein called RAS, which drives many cancers (like pancreatic cancer). Unlike older drugs that only work on 'sleeping' RAS, its…
Source: Fund website
15 Jul 2026Aswath Damodaran (Musings on Markets)Article~15 min
Country Risk: Drivers, Measures and Investment Implications - The 2026 Edition!
This article explains that country risk—like political instability or economic crisis—can no longer be avoided by diversifying across countries, because markets crash together in bad times. Valuation…
Source: Fund website
15 Jul 2026Rick Rule (Rule Investment Media)Article~11 min
Rule Symposium highlights 2026 — Rule Investment Newsletter #17
Gold and silver have dropped sharply, but experts at a recent investment conference say this is a healthy pullback in a long-term bull market, not the end. They recommend buying the dip, especially di…
Source: Fund website
15 Jul 2026Akre Capital ManagementQuarterly~17 min
Akre Focus ETF Quarterly Commentary
This quarterly commentary explains why the Akre Focus Fund trailed the S&P 500 badly (up only 0.66% vs 15.20% in Q2) but argues its holdings are in the strongest fundamental shape in a decade. The man…
Source: Fund website
15 Jul 2026Baillie GiffordDeep research~7 min
Monks’ musings: winning the long race
This article explains how the Monks fund picks stocks in the AI boom. They split the market into three groups: AI hardware, digital services, and industrial stocks. Instead of chasing every AI name, t…
Source: Fund website
10 Jul 2026Patient Capital ManagementQuarterly~11 min
Finding Patience in... an Early 2000s Hip-Hop Song?
This report says the stock market is booming and people are getting overconfident. The author instead bought beaten-down healthcare stocks and beat the market. His advice: when everyone is euphoric, s…
Source: Fund website
10 Jul 2026Sands CapitalDeep research~3 min
Remembering Ian Ratcliffe
This is a tribute to Ian Ratcliffe, who built Sands Capital's life sciences investing unit. The core message: investing in people is more important than models or short-term numbers. For everyday inve…
Source: Fund website
10 Jul 2026Baillie GiffordDeep research~5 min
Medpace: easing the bottleneck in drug development
This article highlights Medpace, a company that runs clinical trials for drug developers—think of it as a 'picks and shovels' business in a tough industry. Drug development is getting harder and more…
Source: Fund website
9 Jul 2026Hosking PartnersReport
Value Investing with Legends Podcast
This deep-dive analyzed a legal disclaimer from Hosking Partners LLP—just regulatory registrations and standard risk warnings. It contains no investment insights, market analysis, or actionable ideas.…
Author · Django DavidsonSource: Fund website
9 Jul 2026Robotti & CompanyLetter~11 min
Letter to the Board of McDermott International
Robotti & Company向麦克德莫特国际(McDermott)董事会发出公开信,反对其拟议的配股发行方案,要求为所有股东提供超额认购权。信中批评配股定价严重低估公司价值,每股1.5美元对应仅约5100万美元股权,而公司营收达100亿美元、EBITDA约4.89亿美元且现金充裕,同时该结构将未认购股份不公平地分配给四名内部救助方,导致其他股东持股比例遭92%稀释,董事会缺乏独立估值与公平性。
Source: SEC EDGAR / fund site
9 Jul 2026Patient Capital ManagementQuarterly~25 min
2Q26 Portfolio Activity & Attribution
This report shows how a professional fund manager beat the stock market by 2% in the second quarter of 2026. His big wins came from healthcare stocks (UnitedHealth rose 54%, CVS 45%) and new bets on p…
Source: Fund website
9 Jul 2026Scottish Mortgage (Baillie Gifford)Article
Baillie Gifford Scottish Mortgage Investment Trust Factsheet
Source: Fund website